How hypocapnia and perfusion interact in orthostatic symptoms
Standard orthostatic testing measures heart rate and blood pressure. It does not measure CO₂. This omission matters more than it appears. CO₂ is one of the most potent regulators of cerebral blood vessel tone in the body — changes in CO₂ of as little as 10 mmHg can produce cerebral blood flow changes of 20-30%. When a patient stands up and their breathing pattern shifts, CO₂ changes. Those CO₂ changes drive changes in cerebral perfusion independently of what heart rate and blood pressure are doing. A 2014 review by Lewis and colleagues — synthesizing the evidence on CO₂ and orthostatic physiology — explains in systematic detail why CO₂ monitoring belongs in orthostatic evaluation, and why leaving it out produces an incomplete picture of what is driving symptoms in orthostatic intolerance conditions.
Why CO₂ Is Not a Peripheral Variable in Orthostatic Physiology
Carbon dioxide is the primary chemical regulator of cerebral vascular tone. Cerebral arterioles respond to changes in arterial CO₂ concentration through a mechanism called cerebrovascular reactivity: when CO₂ rises (hypercapnia), cerebral arterioles dilate, increasing cerebral blood flow; when CO₂ falls (hypocapnia), cerebral arterioles constrict, reducing cerebral blood flow. This is not a subtle or slow effect. The cerebrovascular response to CO₂ is fast — operating over seconds to minutes — and the magnitude is large. A reduction in end-tidal CO₂ of 10 mmHg, which is well within the range that can occur during standing in susceptible patients, can reduce cerebral blood flow velocity by 20 to 30 percent.
This means that CO₂ changes during orthostatic challenge are a direct driver of cerebral blood flow changes — changes that are entirely invisible to heart rate and blood pressure monitoring. Two patients can have identical heart rate and blood pressure responses during a tilt test and show dramatically different cerebral blood flow responses if one is hyperventilating slightly and reducing CO₂ while the other maintains eucapnia. The tachycardia threshold and blood pressure criteria capture nothing about this CO₂-driven cerebrovascular component of orthostatic stress.
Postural Hyperventilation: The Mechanism That Connects Standing to CO₂
The Lewis review explains the mechanism by which upright posture produces CO₂ changes in susceptible patients. Postural hyperventilation — an increase in breathing rate and depth that occurs specifically in the upright position — has been documented in POTS and related conditions. When a patient stands and begins to hyperventilate, they blow off more CO₂ than normal, reducing arterial CO₂ concentration. The brain's CO₂ chemoreceptors detect the falling CO₂ and the arterioles constrict in response, reducing cerebral blood flow. If the patient is also experiencing reduced cerebral perfusion from the gravitational challenge of upright posture and inadequate cardiovascular compensation, the CO₂-driven vasoconstriction compounds an already-stressed cerebrovascular environment.
The combined effect can be substantial. A patient who stands, pools blood in the lower extremities (reducing venous return and cardiac output), compensates with tachycardia (which may or may not maintain adequate cerebral perfusion), and simultaneously hyperventilates (reducing CO₂ and causing cerebrovascular constriction) is experiencing two simultaneous mechanisms reducing brain blood flow. Standard tilt testing detects the tachycardia and may detect the hemodynamic change if it crosses threshold. It detects nothing about the CO₂ and cerebrovascular component.
What End-Tidal CO₂ Monitoring Adds to Orthostatic Evaluation
End-tidal CO₂ monitoring — capnography — measures the CO₂ concentration in exhaled air at the end of each breath, which closely approximates arterial CO₂ concentration in patients with normal lung function. A capnograph is not a specialized research instrument. It is standard equipment in many clinical settings and can be added to tilt table protocols without significant infrastructure investment. Continuous capnography during tilt testing provides real-time data on whether the patient's CO₂ is falling during the test and by how much.
When end-tidal CO₂ is monitored during tilt, two things become visible that are invisible with standard monitoring. First, which patients are hyperventilating during orthostatic challenge — the CO₂ falls detectably during the test as they breathe faster. Second, the magnitude of CO₂ reduction — how large a cerebrovascular vasoconstriction signal is being generated by the breathing pattern change. A patient who drops 5 mmHg of end-tidal CO₂ during tilt is generating a different cerebrovascular response than one who drops 15 mmHg, and that difference is clinically significant for understanding their symptom pattern and for directing management.
The Lewis review describes several studies in which CO₂ monitoring during orthostatic challenge revealed substantial CO₂ falls in symptomatic patients — falls that correlated with cerebral blood flow reduction measured simultaneously. In some patients, the CO₂-driven component of cerebral hypoperfusion was larger than the blood pressure or cardiac output component. In those patients, treating the orthostatic physiology with volume loading or beta-blockers without addressing the CO₂ component addresses a less-important contributor to the actual problem.
CO₂ as a Treatment Target, Not Just a Monitoring Variable
If postural hyperventilation and CO₂ reduction are contributing to orthostatic symptoms through cerebrovascular vasoconstriction, CO₂ management becomes a treatment target, not just a monitoring variable. The Stewart 2018 research on postural hyperventilation in POTS established that inhaling a CO₂-enriched gas mixture during tilt reversed the cerebral blood flow reduction and improved symptoms — demonstrating directly that CO₂ is not just correlated with orthostatic symptoms but causally driving them in patients with postural hyperventilation patterns.
Breathing retraining — techniques that teach patients to breathe more slowly and deeply, avoiding the rate-driven CO₂ fall that occurs with postural hyperventilation — is an accessible intervention for this mechanism. It requires no medication, no specialized equipment, and can be taught by a respiratory therapist or pulmonologist as part of an integrated dysautonomia management approach. For patients in whom CO₂ monitoring identifies postural hyperventilation as a significant contributor to orthostatic symptoms, breathing pattern modification is a logical first-line intervention that standard management protocols typically do not include because standard monitoring does not detect the CO₂ component.
Why This Argument Still Needs to Be Made
The Lewis review was published in 2014. The argument it makes — that CO₂ monitoring belongs in orthostatic evaluation because CO₂ is a primary driver of cerebrovascular responses that standard vital sign monitoring cannot detect — has a clear and logical physiological basis. Capnography is not a research-only instrument. And yet routine orthostatic testing in clinical autonomic laboratories still typically does not include CO₂ monitoring in 2025.
The gap between what the physiology indicates is necessary for a complete orthostatic evaluation and what standard clinical protocols actually measure is a persistent feature of dysautonomia care. CO₂ monitoring is one element of that gap. Cerebral blood flow measurement is another. Transcranial Doppler, which provides real-time cerebral blood flow velocity during tilt, is a third. Standard protocols have evolved slowly, and the tools capable of detecting the mechanisms that drive symptoms in orthostatic intolerance have not been incorporated into the routine testing that most patients receive.
For patients trying to advocate for more thorough evaluation, the Lewis review provides a specific, logical, peer-reviewed argument for why CO₂ monitoring belongs in any orthostatic test that aims to understand why symptoms occur. The question to bring to a clinician is not just whether heart rate crossed 30 bpm. It is what CO₂ was doing during the test, what cerebral blood flow was doing, and whether the evaluation was using tools capable of seeing the mechanisms that the physiology indicates are driving the condition.